Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1960 2
1966 1
1967 2
1973 2
1980 1
1981 1
1982 1
1983 2
1984 1
1985 1
1987 1
1988 1
1991 1
1996 1
1997 1
1998 2
1999 3
2000 1
2001 6
2002 4
2003 2
2004 2
2006 1
2007 1
2008 7
2009 3
2010 4
2011 2
2012 3
2013 5
2014 4
2015 7
2016 5
2017 5
2018 8
2019 6
2020 6
2021 7
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

102 results
Results by year
Filters applied: . Clear all
Page 1
Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance.
Ramsey LB, Balis FM, O'Brien MM, Schmiegelow K, Pauley JL, Bleyer A, Widemann BC, Askenazi D, Bergeron S, Shirali A, Schwartz S, Vinks AA, Heldrup J. Ramsey LB, et al. Among authors: o brien mm. Oncologist. 2018 Jan;23(1):52-61. doi: 10.1634/theoncologist.2017-0243. Epub 2017 Oct 27. Oncologist. 2018. PMID: 29079637 Free PMC article.
Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia.
von Stackelberg A, Locatelli F, Zugmaier G, Handgretinger R, Trippett TM, Rizzari C, Bader P, O'Brien MM, Brethon B, Bhojwani D, Schlegel PG, Borkhardt A, Rheingold SR, Cooper TM, Zwaan CM, Barnette P, Messina C, Michel G, DuBois SG, Hu K, Zhu M, Whitlock JA, Gore L. von Stackelberg A, et al. Among authors: o brien mm. J Clin Oncol. 2016 Dec 20;34(36):4381-4389. doi: 10.1200/JCO.2016.67.3301. Epub 2016 Oct 31. J Clin Oncol. 2016. PMID: 27998223 Clinical Trial.
Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia.
Bhojwani D, Sposto R, Shah NN, Rodriguez V, Yuan C, Stetler-Stevenson M, O'Brien MM, McNeer JL, Quereshi A, Cabannes A, Schlegel P, Rossig C, Dalla-Pozza L, August K, Alexander S, Bourquin JP, Zwaan M, Raetz EA, Loh ML, Rheingold SR. Bhojwani D, et al. Among authors: o brien mm. Leukemia. 2019 Apr;33(4):884-892. doi: 10.1038/s41375-018-0265-z. Epub 2018 Sep 28. Leukemia. 2019. PMID: 30267011 Free PMC article.
Meckel's Masquerade: Penetrating the Disguise.
Callanan DL, O'Brien MM. Callanan DL, et al. Among authors: o brien mm. Pediatr Emerg Care. 2021 Oct 1;37(10):e669-e671. doi: 10.1097/PEC.0000000000002537. Pediatr Emerg Care. 2021. PMID: 34507344
Experience with ponatinib in paediatric patients with leukaemia.
Rossoff J, Huynh V, Rau RE, Macy ME, Sulis ML, Schultz KR, Burke MJ, Athale U, O'Brien MM, Gregory JJ Jr, van der Sluis IM, Keller FG, Zwaan CM, Suttorp M, Hijiya N. Rossoff J, et al. Among authors: o brien mm. Br J Haematol. 2020 Apr;189(2):363-368. doi: 10.1111/bjh.16338. Epub 2020 Jan 24. Br J Haematol. 2020. PMID: 31975387
Toxicity of Cancer Therapy in Adolescents and Young Adults (AYAs).
Bukowinski AJ, Burns KC, Parsons K, Perentesis JP, O'Brien MM. Bukowinski AJ, et al. Among authors: o brien mm. Semin Oncol Nurs. 2015 Aug;31(3):216-26. doi: 10.1016/j.soncn.2015.05.003. Epub 2015 May 7. Semin Oncol Nurs. 2015. PMID: 26210200 Review.
102 results